These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 28833627)

  • 1. Deconstructing Quinoline-Class Antimalarials to Identify Fundamental Physicochemical Properties of Beta-Hematin Crystal Growth Inhibitors.
    Olafson KN; Nguyen TQ; Vekilov PG; Rimer JD
    Chemistry; 2017 Oct; 23(55):13638-13647. PubMed ID: 28833627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of hematin crystallization and inhibition by the antimalarial drug chloroquine.
    Olafson KN; Ketchum MA; Rimer JD; Vekilov PG
    Proc Natl Acad Sci U S A; 2015 Apr; 112(16):4946-51. PubMed ID: 25831526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimalarials inhibit hematin crystallization by unique drug-surface site interactions.
    Olafson KN; Nguyen TQ; Rimer JD; Vekilov PG
    Proc Natl Acad Sci U S A; 2017 Jul; 114(29):7531-7536. PubMed ID: 28559329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thermodynamic factors controlling the interaction of quinoline antimalarial drugs with ferriprotoporphyrin IX.
    Egan TJ; Mavuso WW; Ross DC; Marques HM
    J Inorg Biochem; 1997 Nov; 68(2):137-45. PubMed ID: 9336973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quinoline antimalarials decrease the rate of beta-hematin formation.
    Egan TJ; Ncokazi KK
    J Inorg Biochem; 2005 Jul; 99(7):1532-9. PubMed ID: 15927260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of LAR and VAR on Para-Aminopyridine Antimalarials Targetting Haematin in Chloroquine-Resistance.
    Warhurst DC; Craig JC; Raheem KS
    PLoS One; 2016; 11(8):e0160091. PubMed ID: 27483471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of chloroquine and its analogues with heme: An isothermal titration calorimetric study.
    Bachhawat K; Thomas CJ; Surolia N; Surolia A
    Biochem Biophys Res Commun; 2000 Oct; 276(3):1075-9. PubMed ID: 11027592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonclassical mechanisms to irreversibly suppress β-hematin crystal growth.
    Ma W; Balta VA; Pan W; Rimer JD; Sullivan DJ; Vekilov PG
    Commun Biol; 2023 Jul; 6(1):783. PubMed ID: 37500754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of the NP-40 detergent-mediated assay in discovery of inhibitors of beta-hematin crystallization.
    Sandlin RD; Carter MD; Lee PJ; Auschwitz JM; Leed SE; Johnson JD; Wright DW
    Antimicrob Agents Chemother; 2011 Jul; 55(7):3363-9. PubMed ID: 21518844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions of quinoline antimalarials with hematin in solution.
    Egan TJ
    J Inorg Biochem; 2006 May; 100(5-6):916-26. PubMed ID: 16384600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insights into the mechanism of action of ferroquine. Relationship between physicochemical properties and antiplasmodial activity.
    Biot C; Taramelli D; Forfar-Bares I; Maciejewski LA; Boyce M; Nowogrocki G; Brocard JS; Basilico N; Olliaro P; Egan TJ
    Mol Pharm; 2005; 2(3):185-93. PubMed ID: 15934779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal nucleation, growth, and morphology of the synthetic malaria pigment beta-hematin and the effect thereon by quinoline additives: the malaria pigment as a target of various antimalarial drugs.
    Solomonov I; Osipova M; Feldman Y; Baehtz C; Kjaer K; Robinson IK; Webster GT; McNaughton D; Wood BR; Weissbuch I; Leiserowitz L
    J Am Chem Soc; 2007 Mar; 129(9):2615-27. PubMed ID: 17290993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quinoline drug-heme interactions and implications for antimalarial cytostatic versus cytocidal activities.
    Gorka AP; de Dios A; Roepe PD
    J Med Chem; 2013 Jul; 56(13):5231-46. PubMed ID: 23586757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Definition of an electronic profile of compounds with inhibitory activity against hematin aggregation in malaria parasite.
    Portela C; Afonso CM; Pinto MM; Ramos MJ
    Bioorg Med Chem; 2004 Jun; 12(12):3313-21. PubMed ID: 15158799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Effects of Quinoline and Non-Quinoline Inhibitors on the Kinetics of Lipid-Mediated β-Hematin Crystallization.
    Fitzroy SM; Gildenhuys J; Olivier T; Tshililo NO; Kuter D; de Villiers KA
    Langmuir; 2017 Aug; 33(30):7529-7537. PubMed ID: 28689414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimalarial Quinoline Drugs Inhibit β-Hematin and Increase Free Hemin Catalyzing Peroxidative Reactions and Inhibition of Cysteine Proteases.
    Herraiz T; Guillén H; González-Peña D; Arán VJ
    Sci Rep; 2019 Oct; 9(1):15398. PubMed ID: 31659177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ferriprotoporphyrin IX, phospholipids, and the antimalarial actions of quinoline drugs.
    Fitch CD
    Life Sci; 2004 Mar; 74(16):1957-72. PubMed ID: 14967191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting of hematin by the antimalarial pyronaridine.
    Auparakkitanon S; Chapoomram S; Kuaha K; Chirachariyavej T; Wilairat P
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2197-200. PubMed ID: 16723583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Docking studies on the binding of quinoline derivatives and hematin to Plasmodium falciparum lactate dehydrogenase.
    Cortopassi WA; Oliveira AA; Guimarães AP; Rennó MN; Krettli AU; França TC
    J Biomol Struct Dyn; 2011 Aug; 29(1):207-18. PubMed ID: 21696234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haematin (haem) polymerization and its inhibition by quinoline antimalarials.
    Ridley RG; Dorn A; Vippagunta SR; Vennerstrom JL
    Ann Trop Med Parasitol; 1997 Jul; 91(5):559-66. PubMed ID: 9329993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.